Update on intratympanic gentamicin for meniere’s disease

148Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objective:To review the literature relating to intratympanic gentamicin injection therapy for Meniere’s disease to detect consistencies and differences that might suggest optimal technique. Design:Retrospective literature review. Methods:Eighteen papers from the literature regarding clinical experience with intratympanic gentamicin injections for treatment of Meniere’s disease were reviewed and tabulated. Results:All papers reported high success rates in treating episodic vertigo of Meniere’s disease, but technique, dose, duration, and treatment philosophy varied considerably. Hearing loss was typically reported in about 30 of patients. Conclusion:No single technique of gentamicin injection has a significant medical advantage over the others. Until controlled studies indicate otherwise, nonmedical needs such as convenience and safety may be considered when choosing a technique. © 2000 Lippincott Williams and Wilkins, Inc.

Cite

CITATION STYLE

APA

Blakley, B. K. (2000). Update on intratympanic gentamicin for meniere’s disease. Laryngoscope, 110(2), 236. https://doi.org/10.1097/00005537-200002010-00009

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free